VNDA – vanda pharmaceuticals inc. (US:NASDAQ)

News

FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness [Yahoo! Finance]
FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness
Vanda Pharmaceuticals (NASDAQ:VNDA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Vanda Pharmaceuticals (NASDAQ:VNDA) was downgraded by analysts at Wall S
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com